对COVID-19和静脉血栓栓塞的潜在常见病原机制的生物信息学分析
Ling Zhang1, Jing Qin1, Peiwu Li1
1Department of Emergency Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Cytokine
|June 23, 2024
概括
患有2019年冠状病毒病 (COVID-19) 的患者面临更高的静脉血栓栓塞 (VTE) 风险. 这项研究确定了常见的分子通路和八个关键基因,为VTE和COVID-19病原体提供了洞察力.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 冠状病毒疾病2019 (COVID-19) 患者表现出高静脉血栓栓塞 (VTE) 率.
- 连接COVID-19和VTE的精确分子机制尚不清楚.
- 对这些分子基础的进一步调查至关重要.
研究的目的:
- 阐明COVID-19和VTE之间共享的分子机制.
- 识别常见的差异表达基因 (DEG) 和调控网络.
- 为了探索这两种情况的潜在诊断标志物.
主要方法:
- 从GEO数据库下载和分析了COVID-19和VTE的基因表达特征.
- 确定了常见的DEG,执行了功能注释,并构建了蛋白质-蛋白质相互作用 (PPI) 网络.
- 为枢纽基因建立了转录因子 (TF) 基因和TF-miRNA调控网络.
主要成果:
- 在COVID-19和VTE之间确定了42种常见的DEG.
- 功能分析揭示了共享的生物功能和信号通路.
- 发现了8个具有诊断潜力的重要枢纽基因 (RSL24D1, RPS17, RPS27, HINT1, COX7C, RPL35, RPL34, NDUFA4).
结论:
- 这项研究强调了COVID-19和VTE的常见病原性途径.
- 已识别的关键基因可能成为机理学研究的新目标.
- 研究结果为了解和潜在地治疗这些相互关联的疾病提供了新的视角.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K


